Challenge: Onset, a New Jersey based pharmaceutical company, challenged us with giving a face-lift to an old product. Tretin-X had been a standard for mid-level plaque psoriasis for years but market share was slowly fading.
Solution: Efficacy + Tolerability = The X Factor. Research showed not only did it connect quickly to identify with the product name, it had tremendous stopping power and its point of difference was easily understood.
A sales support effort was developed including a detailed iPad app, a print version of the app and a waiting room poster.